Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Breast Cancer

  Free Subscription


Articles published in Am J Surg

Retrieve available abstracts of 59 articles:
HTML format



Single Articles


    November 2023
  1. ELSHERIF A, Freyvogel Ramirez M, Moore EC, Dietz JR, et al
    Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.
    Am J Surg. 2023;226:646-651.
    PubMed     Abstract available


    October 2023
  2. PESTANA C, Cairns A, Fang-Chi H, Lombana G, et al
    Rates of high-risk screening prior to a breast cancer diagnosis in patients under age 40.
    Am J Surg. 2023 Oct 11:S0002-9610(23)00504-4. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  3. LUDWIGSON A, Huynh V, Vemuru S, Romandetti K, et al
    Characterizing informational needs and information seeking behavior of patients with breast cancer.
    Am J Surg. 2023 Oct 8:S0002-9610(23)00503-2. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  4. HOUNSCHELL CA, Kilgore LJ, Pruitt P, Wilder C, et al
    Evaluation of learning curve with Indocyanine Green (IcG) versus blue dye for sentinel lymph node biopsy in breast cancer.
    Am J Surg. 2023 Oct 5:S0002-9610(23)00508-1. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  5. FEFFERMAN M, Kuchta K, Nicholson K, Attai D, et al
    Patient values in breast cancer surgical decision-making - The WhySurg study.
    Am J Surg. 2023 Oct 4:S0002-9610(23)00517-2. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  6. NICHOLSON K, Kuchta K, Fefferman M, Pesce C, et al
    Trends in bilateral mastectomy rates among different racial backgrounds: A National Cancer Database study.
    Am J Surg. 2023;226:455-462.
    PubMed     Abstract available


  7. KEARSE L, Goll C, Wise B, Yang S, et al
    Promoting breast health awareness: Can a sensor-enabled training system for patient education help?
    Am J Surg. 2023;226:497-501.
    PubMed     Abstract available


    September 2023
  8. MOTT NM, Huynh V, Vemuru S, Parris HJ, et al
    Barriers and facilitators to measuring patient reported outcomes in an academic breast cancer clinic: An application of the RE-AIM framework.
    Am J Surg. 2023 Sep 15:S0002-9610(23)00474-9. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


    July 2023
  9. MOTEN AS, Grande P, Hendrix A, Fleming MD, et al
    Early-stage breast cancer treatment disparities in the Midsouth: Has anything changed?
    Am J Surg. 2023 Jul 7:S0002-9610(23)00323-9. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  10. DOREN EL, Park K, Olson J
    Racial disparities in postmastectomy breast reconstruction following implementation of the affordable care act: A systematic review using a minority health and disparities research framework.
    Am J Surg. 2023;226:37-47.
    PubMed     Abstract available


  11. CORTINA CS, Kong AL
    Using the tools we have to improve perioperative outcomes for mastectomy patients with severe persistent mental illness.
    Am J Surg. 2023;226:2-3.
    PubMed    


    June 2023
  12. JOEL C, Ciampa M, O'Hara T, Bandera BC, et al
    Effect of three-dimensional intraoperative imaging on surgical outcomes with breast conservation therapy.
    Am J Surg. 2023;225:1009-1012.
    PubMed     Abstract available


    May 2023
  13. CHEN YW, Kim T, Specht MC, Gadd MA, et al
    Time to surgery: A health equity metric in breast cancer patients.
    Am J Surg. 2023 May 25:S0002-9610(23)00210-6. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  14. WEIGEL RJ
    Dr. Kirby Bland: Breast cancer's biggest enemy.
    Am J Surg. 2023 May 25:S0002-9610(23)00198-8. doi: 10.1016/j.amjsurg.2023.
    PubMed    


  15. VASILYEVA E, Nichol A, Bakos B, Barton A, et al
    Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.
    Am J Surg. 2023 May 23:S0002-9610(23)00191-5. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  16. CHUA VH, Chua JH, Aniceto CJ, Antonio JA, et al
    DCIS: When is accelerated partial breast irradiation an option? A meta-analysis on outcomes and eligibility.
    Am J Surg. 2023;225:871-877.
    PubMed     Abstract available


  17. DHAK S, Baliski C, Bakos B
    Factors influencing suboptimal pathologic margins and re-excision following breast conserving surgery for ductal carcinoma in-situ.
    Am J Surg. 2023;225:866-870.
    PubMed     Abstract available


    April 2023
  18. DAS S, Jha AK, Kumar M, Singh PK, et al
    Breast Conservation Surgery can become the treatment of choice for Early Breast Cancer?
    Am J Surg. 2023 Apr 14:S0002-9610(23)00148-4. doi: 10.1016/j.amjsurg.2023.
    PubMed    


    February 2023
  19. SUTTON TL, Patel R, Behrens S, Schwantes I, et al
    Delayed adjuvant endocrine therapy is associated with decreased recurrence-free survival following neoadjuvant chemotherapy for breast cancer.
    Am J Surg. 2023 Feb 24:S0002-9610(23)00088-0. doi: 10.1016/j.amjsurg.2023.
    PubMed     Abstract available


  20. GELLINGS JA, Cortina CS, Jorns JM, Johnson MK, et al
    Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens.
    Am J Surg. 2023;225:304-308.
    PubMed     Abstract available


    January 2023
  21. REYES A, Torregrosa L, Lozada-Martinez ID, Cabrera-Vargas LF, et al
    Breast cancer mortality research in Latin America: A gap needed to be filled.
    Am J Surg. 2023 Jan 12:S0002-9610(23)00009-0. doi: 10.1016/j.amjsurg.2023.
    PubMed    


  22. ESTRADA J, Larson KE, Kilgore LJ, Wagner JL, et al
    Safety of de-escalation of surgical intervention for atypical ductal hyperplasia on percutaneous biopsy: One size does not fit all.
    Am J Surg. 2023;225:21-25.
    PubMed     Abstract available


    December 2022
  23. DESHPANDE AJ, Bhandarkar A, Bobo WV, Bydon M, et al
    Examining the relationship between severe persistent mental illness and surgical outcomes in women undergoing mastectomy for breast cancer.
    Am J Surg. 2022 Dec 28:S0002-9610(22)00827-3. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


  24. ESPOSITO A, Ablah E, Okut H, Tenofsky PL, et al
    Characteristics, treatment and outcomes of HER2 positive male breast cancer.
    Am J Surg. 2022 Dec 9:S0002-9610(22)00791-7. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


  25. ELSHERIF A, Cocco D, Bernard S, Djohan R, et al
    Simultaneous contralateral prophylactic mastectomy compared to unilateral nipple-sparing mastectomy for breast cancer surgical treatment: Are complications higher?
    Am J Surg. 2022 Dec 7:S0002-9610(22)00789-9. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


  26. THOMPSON JL, Wright GP
    Contemporary approaches to the axilla in breast cancer.
    Am J Surg. 2022 Dec 5:S0002-9610(22)00776-0. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


  27. ZHANG C, Kosiorek H, Hammond JB, Jogerst KM, et al
    The impact of mastectomy and reconstruction technique on patient perceived quality of Life.
    Am J Surg. 2022;224:1450-1454.
    PubMed     Abstract available


    November 2022
  28. VALENTE SA, ElSherif A, Tran J, Tu C, et al
    Inflammatory breast cancer and the importance of skin punch biopsy.
    Am J Surg. 2022 Nov 12:S0002-9610(22)00727-9. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


  29. KANDI LA, Hammond JB, Thornburg DA, Jarvis TL, et al
    Can Montgomery tubercles impact aesthetic 3D nipple-areolar complex tattooing? An anatomical, quantitative analysis of breast cancer patients.
    Am J Surg. 2022 Nov 9:S0002-9610(22)00714-0. doi: 10.1016/j.amjsurg.2022.
    PubMed     Abstract available


    October 2022
  30. KO G, Sequeira S, McCready DR, Sarvanantham S, et al
    Utilization of a rapid diagnostic centre during the COVID-19 pandemic reduced diagnostic delays in breast cancer.
    Am J Surg. 2022 Oct 3. pii: S0002-9610(22)00621.
    PubMed     Abstract available


  31. CHENG D, Baynosa J, Cross C, Kirgan D, et al
    Comparing the effect of distance to treatment facility on reconstruction and breast conservation therapy for early-stage invasive ductal carcinoma between the nation and the mountain region.
    Am J Surg. 2022;224:1049-1056.
    PubMed     Abstract available


    September 2022
  32. SINGH R, Cao L, Sarode AL, Kharouta M, et al
    Trends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database.
    Am J Surg. 2022 Sep 25. pii: S0002-9610(22)00592.
    PubMed     Abstract available


  33. ROONEY MM, Thomas SM, Taskindoust M, Greenup RA, et al
    The role of tumor phenotype in the surgical treatment of early-stage breast cancer.
    Am J Surg. 2022 Sep 22. pii: S0002-9610(22)00576.
    PubMed     Abstract available


  34. JATANA S, Zahra S, Miron AD, Antonacci G, et al
    A retrospective study evaluating outcomes of surgical excision versus radiologic follow-up of benign breast papillomas without atypia.
    Am J Surg. 2022;224:932-937.
    PubMed     Abstract available


  35. MOHAN SC, Siegel E, Tran H, Ozcan L, et al
    Effects of paravertebral blocks versus liposomal bupivacaine on hospital utilization after mastectomy with reconstruction.
    Am J Surg. 2022;224:938-942.
    PubMed     Abstract available


    August 2022
  36. NNOROM SO, Akinyemi O, Tran J, Baig H, et al
    Color or money?: The impact of socioeconomic status and race/ethnicity on breast cancer mortality.
    Am J Surg. 2022 Aug 24. pii: S0002-9610(22)00456.
    PubMed     Abstract available


  37. AZIN A, Tahmasebi H, Brar A, Azin S, et al
    Racial, ethnic and socioeconomic disparities in diagnosis, treatment, and survival of patients with breast cancer.
    Am J Surg. 2022 Aug 5. pii: S0002-9610(22)00448.
    PubMed     Abstract available


  38. KRIPALANI S, Kulshreshta S, Saracco B, Meterissian S, et al
    The effect of COVID-19 on breast cancer care and treatment in North America: A scoping review.
    Am J Surg. 2022 Aug 3. pii: S0002-9610(22)00460.
    PubMed     Abstract available


  39. WETZEL CL, Gardiner SK, Johnson N, Garreau JR, et al
    Variation in adoption of skin and nipple sparing mastectomy: An opportunity to enhance patient outcomes.
    Am J Surg. 2022;224:710-715.
    PubMed     Abstract available


  40. BALISKI C, Bakos B
    Patient reported outcomes following breast conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal.
    Am J Surg. 2022;224:716-721.
    PubMed     Abstract available


    July 2022
  41. HAMMOND JB, Foley BM, Kosiorek HE, Cronin PA, et al
    Seldom one and done: Characterizing rates of reoperation with direct-to-implant breast reconstruction after mastectomy.
    Am J Surg. 2022;224.
    PubMed     Abstract available


    May 2022
  42. FASANO GA, Bayard S, Tamimi R, Bea V, et al
    Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.
    Am J Surg. 2022 May 27. pii: S0002-9610(22)00391.
    PubMed     Abstract available


  43. KHUBCHANDANI JA, Greenup RA
    Time to surgery delays: Barriers to care for black women with breast cancer.
    Am J Surg. 2022 May 21. pii: S0002-9610(22)00308.
    PubMed    


  44. FAYANJU OM, Fieber JH
    Redressing breast cancer screening disparities during the COVID-19 pandemic: Turning crisis into opportunity.
    Am J Surg. 2022 May 14. pii: S0002-9610(22)00309.
    PubMed    


    April 2022
  45. HEWITT KC, Miller P, Piper M, Prionas N, et al
    Positive margins after mastectomy in patients with invasive lobular carcinoma of the breast: Incidence and management strategies.
    Am J Surg. 2022;223:699-704.
    PubMed     Abstract available


    March 2022
  46. KAPUR H, Bazzarelli A, Warburton R, Pao JS, et al
    Accuracy of preoperative imaging estimates: Opportunities to de-escalate surgery for early invasive breast cancer.
    Am J Surg. 2022 Mar 31. pii: S0002-9610(22)00232.
    PubMed     Abstract available



  47. Trends of contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:538.
    PubMed    


  48. KELLY-SCHUETTE KA, Wempe K, Fritz GD, Hop A, et al
    Masculinizing chest surgery for gender affirmation: A retrospective study of outcomes and patient reported satisfaction.
    Am J Surg. 2022;223:577-580.
    PubMed     Abstract available


  49. ELSHERIF A, Armanyous S, Gentle CK, Al-Hilli Z, et al
    Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    Am J Surg. 2022;223:533-537.
    PubMed     Abstract available


    February 2022
  50. ELSHERIF A, Armanyous S, Valente S
    Mastectomy options for the treatment of breast cancer recurrence after lumpectomy.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00083.
    PubMed    


  51. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer.
    Am J Surg. 2022 Feb 10. pii: S0002-9610(22)00084.
    PubMed    


  52. CROWN A, Buchanan C
    My surgical practice: Presenting aesthetic flat closure as an equal option to mastectomy with reconstruction and technical considerations to optimize cosmesis.
    Am J Surg. 2022;223:436-437.
    PubMed    


    January 2022
  53. JOSEPH KA
    Addressing breast cancer surgical disparities using a community-clinical linkage patient navigation model strategy in a NYC hospital system.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00015.
    PubMed    


  54. JAIN U, Jain B, Fayanju OM, Chino F, et al
    Disparities in timely treatment among young women with breast cancer.
    Am J Surg. 2022 Jan 22. pii: S0002-9610(22)00020.
    PubMed     Abstract available


  55. BECK AC, Fu SL, Liao J, Bashir A, et al
    Risk management recommendations and patient acceptance vary with high-risk breast lesions.
    Am J Surg. 2022;223:94-100.
    PubMed     Abstract available


    December 2021
  56. ELSHERIF A, Armanyous S, Al-Hilli Z, Valente SA, et al
    Mastectomy options for the treatment of ipsilateral breast cancer recurrence after lumpectomy.
    Am J Surg. 2021 Dec 15. pii: S0002-9610(21)00713.
    PubMed     Abstract available


    November 2021
  57. SARGENT RE, Vazquez E, Kang I, Lu J, et al
    Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer at a safety net medical center.
    Am J Surg. 2021 Nov 16. pii: S0002-9610(21)00676.
    PubMed     Abstract available


    October 2021
  58. CHAGPAR AB, Dupont E, Chiba A, Levine EA, et al
    Are we choosing wisely? Drivers of preoperative MRI use in breast cancer patients.
    Am J Surg. 2021 Oct 23. pii: S0002-9610(21)00620.
    PubMed     Abstract available


  59. MANDELBAUM A, Nakhla M, Seo YJ, Dobaria V, et al
    National trends and predictors of mastectomy with immediate breast reconstruction.
    Am J Surg. 2021;222:773-779.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.